Patent · US Active

CTLA4-Ig immunoadhesins

US8329867B2 · kind B2 · utility

53Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 22, 2011
Grant dateDec 11, 2012
Priority date—
Expiry dateFeb 22, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/74
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to CTLA4-Ig immunoadhesins that target CD80 and CD86, and their use, particularly for therapeutic purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.